- Projects of AI
- Posts
- 💊 Generative AI to Autonomously design New Drugs
💊 Generative AI to Autonomously design New Drugs
📰 X and Grok to create real-time AI news
Welcome 🤖
If you`re on Twitter, you must have seen Grok summarizing tweets around a similar topic in “news” format. These will consider tweets as the ground truth instead of using traditional media articles.
In today`s Projects of AI:
X and Grok to create real-time AI news.
Generative AI to autonomously design new drugs.
Nvidia powered DrEureka can automate robot training.
Versatile Design AI platform for Content Creation: Visme
5 Latest AI Projects to Try (AI Tools)
Quick Hits (Latest News)
You Read. We Listen. Let us know what you think by replying to this email.
Read Time: 2 Minutes 35 Seconds
X/Twitter
X Launched AI-Powered ‘Stories’ for Summarized News
Image: X
The Details:
X (formerly Twitter) has launched ‘Stories’, a new feature providing AI-generated summaries of trending news conversations on its Explore page, available to Premium subscribers.
Powered by Elon Musk`s Grok AI chatbot, stories summarizes discussions and reactions around news topics shared on X, rather than directly summarizing articles.
This approach prioritizes what X users are discussing, including personal opinions, which tech experts argue could lead to misinformation or skewed representations.
While Grok doesn`t cite sources well yet, Musk says better citations are coming, allowing users to dive deeper into published stories.
Why it matters: X`s move to leverage AI for condensed news delivery reflects a broader industry shift with potential upsides and risks. While increasing engagement, the summarization of social conversations over original reporting could jeopardize traffic to news websites. This innovative yet controversial approach exemplifies the complex implications as AI shapes information consumption.
AI Research
Generative AI Poised to Autonomously Design New Drugs
The Details:
Generative AI is on the verge of autonomously designing new drugs, a capability that could become widespread in the pharmaceutical industry within a few years.
AI has already generated novel molecular structures unseen in existing databases at companies like Eli Lilly, showcasing its ability to discover innovative drug candidates beyond traditional human approaches.
Following initiatives like DeepMind`s AlphaFold, AI can rapidly explore therapeutic possibilities, from new small molecules to proteins and biologics, promising higher success rates and reduced development timelines.
Why it matters: AI`s growing role in drug discovery represents a paradigm shift from traditional labor-intensive methods toward more systematic, data-driven empirical models. While still requiring human clinical trials, this iterative AI approach is redefining how new therapies are developed, unlocking therapeutic opportunities previously out of reach through autonomous design capabilities.
NVIDIA
NVIDIA Unveils DrEureka for Automated Robot Training
Image: NVIDIA
The Details:
NVIDIA has revealed DrEureka, an AI system that automates the entire process of transferring robotic skills learned in simulation to real-world environments.
Building on NVIDIA`s previous Eureka project, DrEureka is a more advanced AI that writes its own code to train robots in simulations and automatically deploys these skills to physical robots.
Significantly, DrEureka eliminates the need for manual parameter adjustments like gravity and friction, handling this automatically and even explaining the changes it makes.
Why it matters: Transitioning skills from simulation to reality has been a major robotics hurdle. DrEureka`s automated sim-to-real transfer learning represents a breakthrough that could accelerate real-world robotic deployments by leveraging advanced AI to streamline the training process end-to-end.
🤖 Visme — Versatile Design Platform for Standout Content
Image: Visme
The Key Points:
Visme is a user-friendly design tool ideal for creating engaging visuals, especially helpful for non-designers looking to make their content stand out.
It offers a vast collection of customizable templates across various content types, along with branding tools to maintain consistent styling with logos, fonts, and colors.
Visme streamlines content management with integrated social media planning and provides assets like photos, icons, videos, and 3D graphics to enhance designs with interactive elements.
This intuitive platform empowers users to transform dry data into captivating visuals that simplify complex information. With centralized branding and content creation/distribution, Visme is a powerful solution for elevating brand presence through compelling, on-brand designs.
🔵 Bluedot: First AI Note Taker backed by Google that records your meetings without bots joining the call. (link)
💬 ReplyGuy: The AI that plugs your product on Reddit and Twitter (link)
🤖 Build AI: No-Code platform for creating an AI web app. (link)
🚀 M1-Project: Craft your start-up`s winning marketing strategy with AI.(link)
📊 Rows: Combine the power of a spreadsheet with built-in integrations from your business apps. (link)
Warren Buffet predicted that AI scamming will become a ‘growth industry’. saying it has ‘enormous potential’ for both good and harm.
Samsung`s upcoming Galaxy S25 series is rumored to feature a ‘Battery AI’, using the tech to optimize battery life by automatically shutting down unnecessary tasks.
OpenAI CEO Sam Altman promises “with a high degree of scientific certainty” that GPT-5 will be smarter than the “mildly embarrassing at best” GPT-4.
Country Singer Randy Travis has released a new song, “Where That Came From,” his first since losing his voice to a stroke in 2013.
Humans now share the web equally with bots, report warns amid fears of the ‘dead internet’.
Tesla shared a new video of its Optimus humanoid robot sorting battery cells and walking around the office, showing off precision and dexterity.
Your thoughts mean a lot! Please take a minute to give us your feedback.
We read your emails, comments and poll replies daily.
What`d you think of today`s edition? |
Until next time, Stay Informed!-
Reply